Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fabernovel is a global digital transformation agency and innovation consultancy that provides strategic, design, and engineering services. While not a traditional biotech or pharmaceutical company, it maintains a significant presence in the healthcare and life sciences sectors by helping organizations navigate digital health, patient experience, and data-driven innovation. The company specializes in creating digital products, optimizing customer journeys, and implementing emerging technologies for major healthcare providers and pharmaceutical firms. In 2022, Fabernovel was acquired by EY (Ernst & Young) to strengthen its digital consulting capabilities and expand its reach in the health technology space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fabernovel.